Scientist-I
Medicinal Chemistry · India · 2025-01-29
Proposed Endeavor
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.
Framework Evaluation
3 of 3 criteria metThe endeavor addresses urgent healthcare challenges including drug-resistant infections and drug safety.
The petitioner's Ph.D., 22 publications, and 547 citations demonstrate his ability to produce impactful research.
The petitioner's record of original research and capacity to advance drug discovery makes a waiver beneficial to the U.S.
Why This Petition Was Approved
Evidence
Similar Cases
Research Assistant
Pharmaceuticals · China
Scientist
Pharmaceuticals · Bangladesh
Others
Pharmaceuticals · South Korea
Research Scientist
Pharmaceuticals · China
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-29.
Browse all casesAt a Glance
EB-2 (NIW) Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist